EN
中文 EN
  • 650+

    Peer-reviewed Articles

    UP TO 2026.06

  • 4700+

    lmpact Factor

  • 25+

    Tumor Types Involved

Nat Med. | 27-Feb-2025
Cerebrospinal fluid circulating tumor DNA profiling for risk stratification and matched treatment of central nervous system metastases

OncoCompassⓇ Plus (520-gene panel, ctDNA) &OncoCompassⓇ Target (168-gene panel, ctDNA) | NSCLC

Learn More
Nature Med. | 7-Mar-2025
Cost-Effective Identification of Hepatocellular Carcinoma from Cirrhosis or Chronic Hepatitis Virus Infection Using Eight Methylated Plasma DNA Markers

BNR’s qMSP Technology | Hepatocellular Carcinoma

Learn More
J Immunother Cancer. | 29-Nov-2024
Mutation-guided chemotherapy-free strategy in first-line immunotherapy for low PD-L1-expressing non-squamous NSCLC

Non-squamous NSCLC

Learn More
Sci China Life Sci. | Jan-2025
Antithetical impacts of deleterious LRP1B mutations in non-squamous and squamous NSCLCs on predicting benefits from immune checkpoint inhibitor alone or with chemotherapy over chemotherapy alone: retrospective analyses of the POPLAR/OAK and CHOICE-01 trials

OncoCompassⓇ Plus (520-gene Panel, ctDNA) | NSCLC

Learn More
Cancer Cell | 09-Sep-24
Circulating tumor DNA-based stratification strategy for chemotherapy plus PD-1 inhibitor in advanced non-small-cell lung cancer

OncoCompassⓇ Plus (520-gene panel, ctDNA) | NSCLC

Learn More
1 2 3 4 5 6 7 8 9 10 ...
Contact Our Experts
We would like to collect certain personal information about you through cookies and similar technologies in order to personalize the site for you, improve the performance of the site, and support our marketing efforts. By clicking “Accept All”, you confirm that we have your consent to collect and process your personal information in accordance with our Privacy Policy, which may include online targeted and social media advertising in some instances. You can by clicking “Reject All”, you can reject all cookies except for Strictly Necessary Cookies."